Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer

Jeffrey I. Kreisberg, Shazli N. Malik, Thomas J. Prihoda, Roble G. Bedolla, Dean A. Troyer, Suzanne Kreisberg, Paramita M. Ghosh

Research output: Contribution to journalArticlepeer-review

271 Scopus citations

Fingerprint Dive into the research topics of 'Phosphorylation of Akt (Ser<sup>473</sup>) is an excellent predictor of poor clinical outcome in prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences